Aridis Pharmaceuticals Inc. · OTC:ARDS
Armistice Capital, LLC reported a 11.43% stake in Aridis Pharmaceuticals Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Armistice Capital, LLC reported a 11.43% stake in Aridis Pharmaceuticals Inc., 5,096,251 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 11.43%
- Shares
- 5,096,251
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 11.43% | 5,096,251 |
| Steven Boyd | 11.43% | 5,096,251 |
Source
Related
- Aridis Pharmaceuticals Inc.
- Armistice Capital, LLC
- Aridis Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025